Throughout the monkeypox outbreak, numerous countries and communities have sought Bavarian Nordic's JYNNEOS® vaccine to protect people from the fatal disease.
With millions of JYNNEOS doses delivered since May 2022, efficiency questions have remained unanswered.
Unfortunately, a new Research Letter published on September 30, 2022, indicates that the JYNNEOS vaccine does not deliver 100% protection.
Read More
